We are developing a drug to burn calories and increase metabolism…
Obesity and type 2 diabetes are widespread metabolic disorders driven by an imbalance between caloric intake and energy expenditure that existing drugs do not adequately address.
The company is developing a drug that increases metabolism and burns calories by inducing mitochondrial heat production.
Patients with obesity and/or type 2 diabetes treated by healthcare providers.





